Literature DB >> 15605981

Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation.

Jaana Tyynelä1, Jonathan D Cooper, M Nadeem Khan, Stephen J A Shemilts, Matti Haltia.   

Abstract

The neuronal ceroid-lipofuscinoses (NCLs) are recessively inherited lysosomal storage diseases, currently classified into 8 forms (CLN1-CLN8). Collectively, the NCLs constitute the most common group of progressive encephalopathies of childhood, and present with visual impairment, psychomotor deterioration and severe seizures. Despite recent identification of the underlying disease genes, the mechanisms leading to neurodegeneration and epilepsy in the NCLs remain poorly understood. To investigate these events, we examined the patterns of storage deposition, neurodegeneration, and glial activation in the hippocampus of patients with CLN1, CLN2, CLN3, CLN5 and CLN8 using histochemistry and immunohistochemistry. These different forms of NCL shared distinct patterns of neuronal degeneration in the hippocampus, with heavy involvement of sectors CA2-CA4 but relative sparing of CA1. This selective pattern of degeneration was also observed in immunohistochemically identified interneurons, which exhibited a graded severity of loss according to phenotype, with calretinin-positive interneurons relatively spared. Furthermore, glial activation was also regionally specific, with microglial activation most pronounced in areas of greatest neuronal loss, and astrocyte activation prominent in areas where neuronal loss was less evident. In conclusion, the NCLs share a common pattern of selective hippocampal pathology, distinct from that seen in the majority of temporal lobe epilepsies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605981     DOI: 10.1111/j.1750-3639.2004.tb00077.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  41 in total

1.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

2.  A Case-controlled Investigation of Pain Experience and Sensory Function in Neuronal Ceroid Lipofuscinosis.

Authors:  Chantel C Barney; John Hoch; Breanne Byiers; Adele Dimian; Frank J Symons
Journal:  Clin J Pain       Date:  2015-11       Impact factor: 3.442

3.  Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Catherine Kielar; Lucy Maddox; Ellen Bible; Charlie C Pontikis; Shannon L Macauley; Megan A Griffey; Michael Wong; Mark S Sands; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2006-10-12       Impact factor: 5.996

4.  Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Attila D Kovács; David A Pearce
Journal:  Biochim Biophys Acta       Date:  2016-04-19

5.  Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Authors:  Colleen S Stein; Paul H Yancey; Inês Martins; Rita D Sigmund; John B Stokes; Beverly L Davidson
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

6.  Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Elena Lysenko; Akiva S Cohen; Beverly L Davidson; Eric D Marsh
Journal:  JCI Insight       Date:  2019-11-01

7.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  More than hypomyelination in Pol-III disorder.

Authors:  Adeline Vanderver; Davide Tonduti; Genevieve Bernard; Jinping Lai; Christopher Rossi; Giovanni Carosso; Martha Quezado; Kondi Wong; Raphael Schiffmann
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

9.  Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL.

Authors:  Carina von Schantz; Catherine Kielar; Stine N Hansen; Charlie C Pontikis; Noreen A Alexander; Outi Kopra; Anu Jalanko; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

10.  Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis.

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Karen J Barwell; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2008-06-25       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.